Chembio to Screen Teens with HIV Rapid Tests
Chembio Diagnostics has completed a clinical study evaluating the performance of its two FDA approved rapid HIV tests in teens 13-17 years old. The objective […]
Chembio Diagnostics has completed a clinical study evaluating the performance of its two FDA approved rapid HIV tests in teens 13-17 years old. The objective […]
BioGlue is now available for use in browlift cosmetic and plastic surgery in the EU. CryoLife, maker of BioGlue, has had its eyes set on […]
NovaDel has entered into a collaboration agreement with BioAlliance Pharma SA for the development and commercialization of NovaDel’s ondansetron oral spray (OS) for Europe. Ondansetron […]
NovaDel entered into a private placement for up to $4 million, in the form of secured convertible promissory notes with an interest rate of 10% […]
Bioject Medical develops and markets needle-free injection technology used to administer injectable medications. Bioject’s technology works by forcing liquid medication at high speed through a […]
Revenues at CryoLife rose 4% to $25.6 million in the first quarter of 2008. Net income was $2.8 million, or $0.10 per share, compared to […]
CryoLife, in a three-year agreement signed last week, will become the exclusive U.S. distributor of Minneapolis, MN-based Medafor’s microporous polysaccharide hemostatic (MPH) agent for use […]
Five cancer cells were injected subcutaneously into the dorsal region near the thigh of mouse. Tumor growth is monitored weekly by an IVIS Spectrum. The […]
Medical technology and device companies interested in raising capital, partnering products or initiating strategic alliances are encouraged to apply for a presentation slot at AdvaMed […]
Minrad’s Image Guidance System is designed to enhance the safety and efficacy of fluoroscopically guided surgery and interventional procedures. The system’s image guidance technology provides […]
Copyright © 2025 | WordPress Theme by MH Themes